71 assets in Primary Central Nervous System Lymphoma

Therapeutic assets addressing Primary Central Nervous System Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Tafasitamab Primary Central Nervous System Lymphoma	James Rubenstein	P1/2	CC (45)
Anti-Cd19 Car-Nk Cells Primary Central Nervous System Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Autologous Cd19-Cd20-Nkg2D-Nsbicephali Car-T Cell Primary Central Nervous System Lymphoma	Beijing Boren Hospital	P1	CC (43)
Axicabtagene Ciloleucel Primary Central Nervous System Lymphoma	Dana-Farber Cancer Institute	P1	CC (43)
Btk-In-24 Primary Central Nervous System Lymphoma	Nurix Therapeutics, Inc.	P1	CC (43)
Lifileucel Primary Central Nervous System Lymphoma	Iovance Biotherapeutics, Inc.	P1	CC (43)
ln-144 Primary Central Nervous System Lymphoma	Iovance Biotherapeutics, Inc.	P1	CC (43)
Mb-Cart19.1 Primary Central Nervous System Lymphoma	Memorial Sloan Kettering Cancer Center	P1	CC (43)
Zelebrudomide Primary Central Nervous System Lymphoma	Nurix Therapeutics, Inc.	P1	CC (43)
cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes Primary Central Nervous System Lymphoma	City of Hope Medical Center	P1	CC (41)
cd19-ucart Primary Central Nervous System Lymphoma	University of Colorado, Denver	P1	CC (41)
gb5121 Primary Central Nervous System Lymphoma	GB005, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.	P1	CC (41)
Golcadomide Primary Central Nervous System Lymphoma	Allison Winter	P1	CC (41)
Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,461-Alanine,462-Alanine,556-Glycine,581-Cysteine,593-Tryptophan), Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 Vh-Ch1 Fragment) Fusion Protein With Peptide (Synthetic 10-Amino Acid Linker) Fusion Protein With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Heavy Chain Vl(.Lambda.)-Ch1-Ch2-Ch3), (222->219''')-Disulfide With Immunoglobulin Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine)) And (447->232'')-Disulfide With Immunoglobulin Anti-(Human Cd3 Antigen .Epsilon.-Chain) (Human-Mus Musculus Monoclonal Rg6026 Light Chain Vh-Cl(.Kappa.)), (453->228'), (456->231'), (581->351')-Tris(Disulfide) With Immunoglobulin G1 (149-Glutamic Acid,215-Glutamic Acid,236-Alanine,237-Alanine,331-Glycine,351-Cysteine,368-Serine,370-Alanine,409-Valine) Anti-(Human Cd20 Antigen) (Human-Mus Musculus Monoclonal Rg6026 .Gamma.1-Chain) Disulfide With Human-Mus Musculus Monoclonal Rg6026 .Kappa.-Chain (128-Arginine,129-Lysine) Primary Central Nervous System Lymphoma	City of Hope Medical Center	P1	CC (41)
Loncastuximab Tesirine Primary Central Nervous System Lymphoma	University of Utah	P1	CC (41)
Mem T-Lymphocytes Primary Central Nervous System Lymphoma	City of Hope Medical Center	P1	CC (41)
Polatuzumab Vedotin Primary Central Nervous System Lymphoma	Juan P. Alderuccio, MD	P1	CC (41)
q702 Primary Central Nervous System Lymphoma	Mayo Clinic	P1	CC (41)
Human Cd19-Cd22 Targeted T Cells Primary Central Nervous System Lymphoma	Hrain Biotechnology Co., Ltd.	Early P1	C (38)
Autologous Cd4+ And Cd8+ T Cells, Enriched From Peripheral Blood Mononuclear Cells (Pbmcs) Transduced With A Nonreplicative Self-Inactivating (Sin) Lentiviral Vector Encoding A Chimeric Antigen Receptor (Car) Consisting Of The Human Cd19-Specific Scfv, An Lgg4 Hinge Region, Cd28 Transmembrane Domain, Cd137 (4-1Bb) Co-Stimulatory Domain And Cd3 Zeta Signalling Domain, Under The Control Of A Hybrid Elongation Factor 1 Alpha (Ef1.Alpha.) And Human T Cell Leukemia Virus Type 1(Htlv-1) Regulatory Element Promoter And Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (Wpre). The Vector Genome Also Encodes A Truncated Human Epidermal Growth Factor Receptor (Egfrt) That Is Co-Expressed With The Car And Cleaved From It By The T2A Self-Cleaving Peptide. The Vector Genome Also Contains A Splice Donor, A Fragment Of Gag, A Rev Response Element (Rre), A Mutated Central Polypurine Tract (Cppt), And A Splice Acceptor Primary Central Nervous System Lymphoma	Zhengzhou University	N/A	D (30)
FET Primary Central Nervous System Lymphoma	Asan Medical Center	N/A	D (30)

Showing 51 to 71 of 71 assets

PreviousPage 2 of 2Next